Filtered By:
Drug: Vytorin
Countries: Spain Health
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 3 results found since Jan 2013.
Cost-effectiveness and Budget Impact of Treatment with Evolocumab Versus Statins and Ezetimibe for Hypercholesterolemia in Spain
Conclusions Treatment with evolocumab is associated with a lower frequency of cardiovascular events, but is inefficient for patients suitable to receive this drug in the Spanish National Health System.
Source: Revista Espanola de Cardiologia - June 22, 2018 Category: Cardiology Source Type: research
